Package Label (Principal Display Panel)
Sevelamer Carbonate For Oral Suspension
Product Images NDC 72823-302
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate For Oral Suspension (NDC 72823-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hangzhou Anprime Biopharm Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label (Principal Display Panel)
Chemical Structure (Figure 01)
Figure 2 (Figure 02)
Figure 3 (Figure 03)
This appears to be a chart showing the reduction in serum phosphorus (mg/dL) for patients using Sevelamer Hydrochloride compared to an active control, with a percentage of patients achieving a reduction greater than "X". However, the output is not entirely clear, so some information may be missing or inaccurate.*
Figure 4 (Figure 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
